deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT00099086

Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer

Phase I Trial of Concurrent Taxotere With Radiation Therapy and Hormonal Therapy For Clinically Localized High Risk Prostate Cancer

Sponsor: Medical University of South Carolina

Conditions Prostate Cancer
Interventions Bicalutamide GnRh analog docetaxel radiotherapy
Updated 18 times since 2017 Last updated: Jan 29, 2024 Started: Jan 16, 2007 Primary completion: Jan 20, 2011 Completion: Dec 13, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00099086, this PHASE1 trial focuses on Prostate Cancer and remains completed. Sponsored by Medical University of South Carolina, it has been updated 18 times since 2007, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~Mar 2018 · 11 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~Jan 2020 · 12 months · monthly snapshot~Jan 2020 – ~Aug 2020 · 7 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Feb 2022 · 12 months · monthly snapshot~Feb 2022 – ~Sep 2022 · 7 months · monthly snapshot~Sep 2022 – ~Mar 2023 · 6 months · monthly snapshot~Mar 2023 – ~Aug 2023 · 5 months · monthly snapshot~Aug 2023 – ~Nov 2023 · 3 months · monthly snapshot~Nov 2023 – ~Feb 2024 · 3 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Feb 2024 — Jul 2024 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  4. Nov 2023 — Feb 2024 [monthly]

    Active Not Recruiting PHASE1

  5. Aug 2023 — Nov 2023 [monthly]

    Active Not Recruiting PHASE1

▶ Show 13 earlier versions

  1. Mar 2023 — Aug 2023 [monthly]

    Active Not Recruiting PHASE1

  2. Sep 2022 — Mar 2023 [monthly]

    Active Not Recruiting PHASE1

  3. Feb 2022 — Sep 2022 [monthly]

    Active Not Recruiting PHASE1

  4. Feb 2021 — Feb 2022 [monthly]

    Active Not Recruiting PHASE1

  5. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting PHASE1

  6. Aug 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1

  7. Jan 2020 — Aug 2020 [monthly]

    Active Not Recruiting PHASE1

  8. Jan 2019 — Jan 2020 [monthly]

    Active Not Recruiting PHASE1

  9. Jun 2018 — Jan 2019 [monthly]

    Active Not Recruiting PHASE1

  10. Mar 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1

  11. Apr 2017 — Mar 2018 [monthly]

    Active Not Recruiting PHASE1

  12. Feb 2017 — Apr 2017 [monthly]

    Active Not Recruiting PHASE1

  13. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE1

    First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medical University of South Carolina
Data source: Medical University of South Carolina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.